Operating
Cencora·Cash Flow Statement·21 metrics
Breakdown
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Change in accounts payable | $3.6B | $855.6M | -$654.2M | -$15.3M | $607.6M | $3.8B | $1.3B | -$3.5B |
| Net income | $487.6M | $7.5M | $493.7M | $717.4M | $689.7M | — | $566.1M | $1.6B |
| Charges (credits) associated with last-in, first-out inventory method | — | — | -$7.3M | $39.5M | -$52.1M | -$57M | -$77.6M | -$210M |
| Deferred income taxes | -$69.9M | $0 | -$5.1M | $26.2M | — | $55.4M | $14.4M | $178.4M |
| Depreciation | $114.3M | $111.2M | $113.6M | $123.6M | $130.4M | $133.7M | $135.2M | $142.3M |
| Amortization | $166.6M | $168.5M | $167.8M | $140.4M | $128.6M | $130.3M | $129M | $120.7M |
| Income taxes payable and other liabilities | -$54.9M | -$106.6M | -$51.2M | -$94.5M | $0 | -$86.3M | -$13.7M | -$78.2M |
| Increase (Decrease) in Prepaid Expense and Other Assets | -$139.1M | — | -$70.3M | -$24M | -$143.5M | — | $14.4M | -$68.5M |
| Contingent consideration fair value adjustments | $0 | — | $0 | $37.5M | $37.5M | — | $42.1M | $55.4M |
| Stock-based compensation | $22.2M | $34.6M | $70.4M | $28.5M | $23.2M | $25.9M | $66.1M | $28M |
| Türkiye highly inflationary impact | $4.5M | $10.6M | $7.7M | $18.4M | $16.8M | $12.7M | $8.7M | $10.5M |
| Accounts Receivable, Credit Loss Expense (Reversal) | $2.6M | $10.6M | $3.9M | $8.5M | $33.2M | $17.8M | $13K | -$4.9M |
| Gain (Loss) on Disposition of Other Assets | — | — | $0 | $0 | — | — | $35.8M | $234K |
| Change in accounts receivable | $1.4B | — | $974.3M | — | $759.6M | $945.8M | $830.8M | — |
| Change in accrued liabilities | $37.1M | $37.1M | -$338.1M | -$151.3M | — | — | -$328.4M | — |
| Change in inventories | $716.6M | $644M | $1.7B | -$1.7B | $984.1M | $319.5M | $3.5B | — |
| Net cash from operating activities | $2.5B | $1B | -$2.7B | $3.4B | $109.2M | $3.1B | -$2.3B | — |
| Asset write-downs | $104.5M | $104.5M | $0 | $0 | — | — | $249.5M | $0 |
| Equity Investment, Remeasurement Gain (Loss) | -$13.3M | — | $3.5M | — | $27.3M | — | $10.5M | — |
| Gain on sale of business and assets | $0 | $0 | -$35.5M | — | — | — | $0 | $0 |
| Other Noncash Income (Expense) | -$1.6M | -$8.3M | -$7M | -$2.8M | $39.8M | $3.6M | -$6.7M | — |